NCT01067417View on ClinicalTrials.gov

Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected Patients

PHASE2UnknownINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
HIV Infections
Interventions
DRUG

Hydroxychloroquine

Taken orally 2x200mg capsules once daily for 48 weeks

DRUG

Placebo

Taken orally 2x200mg capsules once daily for 48 weeks

Sponsors
All Listed Sponsors
collaborator

Wellcome Trust

OTHER

lead

Medical Research Council

OTHER_GOV